https://www.live-feeds.com/feed/ozempic-maker-turns-to-anthropic-to-turbocharge-medical-researchContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/ozempic-maker-turns-to-anthropic-to-turbocharge-medical-researchhttps://www.live-feeds.com/feed/ozempic-maker-turns-to-anthropic-to-turbocharge-medical-research#u73860Fri, 18 Sep 2026 03:41:17 +0000Novo Nordisk is integrating Anthropic's Claude AI to speed up drug development and medical research. The pharmaceutical company, known for producing Ozempic, aims to use the AI tool to optimize the discovery process for new medications. Multiple reports confirm the partnership focuses on leveraging generative AI to shorten the timeline for bringing new drugs to market.Why it mattersDrug discovery is traditionally a slow and expensive process. By adopting advanced AI models, Novo Nordisk seeks to automate data analysis and identify viable drug candidates more efficiently.What is confirmedN